Risk of High-Grade Malignancy (ROHM)

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Based on the premise of The Paris System for Reporting Urinary Cytology (TPS), that the main goal of urine cytology is the detection of clinically significant cancers, particularly high-grade urothelial carcinoma, a new term is coined: risk of high-grade malignancy (ROHM) for each diagnostic category. The reported experience after the implementation of TPS classification worldwide has shown an increased sensitivity in urinary cytology, along with progressively higher ROHM across the diagnostic categories, resulting in updated numbers to the original values cited in the first edition of TPS. These results reflect many publications that reported varied geographic experiences in hospitals and clinical laboratories following the adoption of TPS since its initial publication in 2016.

Cite

CITATION STYLE

APA

Saieg, M., Barkan, G. A., Brimo, F., Chandra, A., Elsheikh, T. M., Pastorello, R. G., … Vielh, P. (2022). Risk of High-Grade Malignancy (ROHM). In The Paris System for Reporting Urinary Cytology: Second Edition (pp. 249–255). Springer International Publishing. https://doi.org/10.1007/978-3-030-88686-8_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free